Sensus Healthcare, Inc. (SRTS)
USD 4.9
(-2.58%)
USD 4.9
(-2.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -382 Thousand USD | -102.58% |
| 2022 | 14.83 Million USD | 259.98% |
| 2021 | 4.12 Million USD | 150.04% |
| 2020 | -8.23 Million USD | -318.33% |
| 2019 | -1.96 Million USD | 1.85% |
| 2018 | -2 Million USD | 46.06% |
| 2017 | -3.71 Million USD | -923.75% |
| 2016 | -363.11 Thousand USD | -64.12% |
| 2015 | -221.25 Thousand USD | 93.99% |
| 2014 | -3.68 Million USD | -3001.48% |
| 2013 | 126.84 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.98 Million USD | -31.35% |
| 2024 Q1 | 2.88 Million USD | -48.23% |
| 2023 Q4 | 5.57 Million USD | 394.3% |
| 2023 Q1 | -2.93 Million USD | -170.43% |
| 2023 Q2 | -1.12 Million USD | 61.65% |
| 2023 Q3 | -1.89 Million USD | -68.15% |
| 2023 FY | -382 Thousand USD | -102.58% |
| 2022 Q3 | 2.16 Million USD | -52.71% |
| 2022 Q4 | 4.17 Million USD | 93.11% |
| 2022 FY | 14.83 Million USD | 259.98% |
| 2022 Q1 | 3.93 Million USD | -26.11% |
| 2022 Q2 | 4.57 Million USD | 16.28% |
| 2021 Q4 | 5.31 Million USD | 2627.69% |
| 2021 Q3 | 195 Thousand USD | 169.89% |
| 2021 Q2 | -279 Thousand USD | 74.98% |
| 2021 FY | 4.12 Million USD | 150.04% |
| 2021 Q1 | -1.11 Million USD | -533.25% |
| 2020 Q2 | -2.57 Million USD | 29.21% |
| 2020 FY | -8.23 Million USD | -318.33% |
| 2020 Q4 | 257.35 Thousand USD | 111.29% |
| 2020 Q3 | -2.27 Million USD | 11.47% |
| 2020 Q1 | -3.63 Million USD | -469.49% |
| 2019 Q4 | 984.39 Thousand USD | 222.26% |
| 2019 FY | -1.96 Million USD | 1.85% |
| 2019 Q2 | 45.48 Thousand USD | 102.07% |
| 2019 Q3 | -805.13 Thousand USD | -1870.18% |
| 2019 Q1 | -2.19 Million USD | -7117.04% |
| 2018 Q4 | 31.25 Thousand USD | 107.38% |
| 2018 FY | -2 Million USD | 46.06% |
| 2018 Q1 | -1.11 Million USD | -178.97% |
| 2018 Q2 | -498.73 Thousand USD | 55.25% |
| 2018 Q3 | -423.35 Thousand USD | 15.11% |
| 2017 Q3 | -965.42 Thousand USD | -26.06% |
| 2017 Q2 | -765.82 Thousand USD | 51.78% |
| 2017 Q1 | -1.58 Million USD | -7929.1% |
| 2017 Q4 | -399.5 Thousand USD | 58.62% |
| 2017 FY | -3.71 Million USD | -923.75% |
| 2016 Q1 | 9588.00 USD | -97.72% |
| 2016 Q2 | -348.77 Thousand USD | -3737.6% |
| 2016 Q3 | -44.22 Thousand USD | 87.32% |
| 2016 FY | -363.11 Thousand USD | -64.12% |
| 2016 Q4 | 20.28 Thousand USD | 145.88% |
| 2015 Q3 | -74.31 Thousand USD | 15.27% |
| 2015 Q1 | -480.42 Thousand USD | 0.0% |
| 2015 FY | -221.25 Thousand USD | 93.99% |
| 2015 Q4 | 421.19 Thousand USD | 666.78% |
| 2015 Q2 | -87.71 Thousand USD | 81.74% |
| 2014 FY | -3.68 Million USD | -3001.48% |
| 2013 FY | 126.84 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 97.34% |
| Cerus Corporation | -30.05 Million USD | 98.729% |
| OrthoPediatrics Corp. | -25.76 Million USD | 98.517% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 96.403% |
| Talis Biomedical Corporation | -66.81 Million USD | 99.428% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 97.791% |
| Inogen, Inc. | -109.38 Million USD | 99.651% |
| Spectral AI, Inc. | -12.98 Million USD | 97.058% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 99.39% |
| CVRx, Inc. | -43.1 Million USD | 99.114% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 89.172% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 96.926% |
| Orthofix Medical Inc. | -139.11 Million USD | 99.725% |
| Venus Concept Inc. | -28.3 Million USD | 98.651% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 99.293% |
| Bioventus Inc. | -81.72 Million USD | 99.533% |
| BrainsWay Ltd. | -4.92 Million USD | 92.247% |
| Envoy Medical, Inc. | -18.37 Million USD | 97.921% |
| electroCore, Inc. | -18.8 Million USD | 97.969% |
| IceCure Medical Ltd | -15.57 Million USD | 97.548% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 99.212% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 97.788% |
| MaxCyte, Inc. | -48.29 Million USD | 99.209% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 96.805% |
| Nexalin Technology, Inc. | -5.69 Million USD | 93.294% |
| PAVmed Inc | -68.79 Million USD | 99.445% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 99.325% |
| RxSight, Inc. | -50.08 Million USD | 99.237% |
| Sight Sciences, Inc. | -57.27 Million USD | 99.333% |
| SI-BONE, Inc. | -46.93 Million USD | 99.186% |
| TELA Bio, Inc. | -44.07 Million USD | 99.133% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 99.295% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 99.257% |
| LivaNova PLC | -68.49 Million USD | 99.442% |
| 908 Devices Inc. | -42.75 Million USD | 99.107% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 99.78% |
| Nemaura Medical Inc. | -9.59 Million USD | 96.019% |
| NeuroPace, Inc. | -27.17 Million USD | 98.594% |
| LENSAR, Inc. | -12.22 Million USD | 96.876% |
| Apyx Medical Corporation | -17.25 Million USD | 97.787% |
| Cutera, Inc. | -156.23 Million USD | 99.755% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 95.56% |
| BioSig Technologies, Inc. | -28.51 Million USD | 98.66% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 99.564% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 98.298% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 100.343% |
| Axonics, Inc. | -26.05 Million USD | 98.534% |
| Outset Medical, Inc. | -169.77 Million USD | 99.775% |
| IRIDEX Corporation | -10 Million USD | 96.183% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 99.65% |
| IRadimed Corporation | 20.03 Million USD | 101.907% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 95.367% |
| INVO Bioscience, Inc. | -6.76 Million USD | 94.355% |
| Telesis Bio, Inc. | -35.15 Million USD | 98.913% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 102.666% |
| Varex Imaging Corporation | 32.1 Million USD | 101.19% |
| Quipt Home Medical Corp. | 3.91 Million USD | 109.747% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 96.852% |
| Pulmonx Corporation | -61.93 Million USD | 99.383% |
| Dynatronics Corporation | -2.27 Million USD | 83.194% |
| Modular Medical, Inc. | -17.52 Million USD | 97.821% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 97.391% |
| Semler Scientific, Inc. | 22.25 Million USD | 101.716% |
| InMode Ltd. | 195.66 Million USD | 100.195% |
| Bruker Corporation | 436.9 Million USD | 100.087% |
| Cytosorbents Corporation | -31.2 Million USD | 98.776% |
| DexCom, Inc. | 597.7 Million USD | 100.064% |
| Align Technology, Inc. | 643.33 Million USD | 100.059% |
| Viveve Medical, Inc. | -21.55 Million USD | 98.228% |
| ZimVie Inc. | -30.93 Million USD | 98.765% |
| Movano Inc. | -29.69 Million USD | 98.713% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 98.628% |
| Nexalin Technology, Inc. | -5.69 Million USD | 93.294% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 89.172% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 99.836% |
| Profound Medical Corp. | -28.61 Million USD | 98.665% |
| Insulet Corporation | 220 Million USD | 100.174% |
| enVVeno Medical Corporation | -25.23 Million USD | 98.486% |
| Surmodics, Inc. | -5.64 Million USD | 93.233% |
| iCAD, Inc. | -7.68 Million USD | 95.032% |
| Nuwellis, Inc. | -17.63 Million USD | 97.833% |
| Biotricity, Inc. | -8.82 Million USD | 95.673% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 99.695% |
| Aethlon Medical, Inc. | -12.63 Million USD | 96.977% |
| InspireMD, Inc. | -21.14 Million USD | 98.193% |
| PAVmed Inc. | -68.79 Million USD | 99.445% |
| BIOLASE, Inc. | -17.93 Million USD | 97.87% |
| Beyond Air, Inc. | -63 Million USD | 99.394% |
| FONAR Corporation | 16.53 Million USD | 102.31% |
| AxoGen, Inc. | -21.46 Million USD | 98.22% |
| Vivani Medical, Inc. | -26.96 Million USD | 98.583% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 102.117% |
| Inari Medical, Inc. | -14.03 Million USD | 97.278% |
| UFP Technologies, Inc. | 57.66 Million USD | 100.662% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 92.248% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 93.942% |
| Tenon Medical, Inc. | -15.72 Million USD | 97.571% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 94.889% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 99.106% |
| AdaptHealth Corp. | -598.4 Million USD | 99.936% |
| Sintx Technologies, Inc. | -13.35 Million USD | 97.14% |
| NanoVibronix, Inc. | -3.43 Million USD | 88.882% |
| Quanterix Corporation | -49.7 Million USD | 99.231% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 96.852% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 99.886% |
| TransMedics Group, Inc. | -28.72 Million USD | 98.67% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 98.382% |
| NeuroMetrix, Inc. | -7.15 Million USD | 94.658% |
| Hyperfine, Inc. | -48.11 Million USD | 99.206% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 99.413% |
| Biomerica, Inc. | -6.36 Million USD | 94.0% |
| Bone Biologics Corporation | -9.42 Million USD | 95.948% |
| AVITA Medical, Inc. | -40.4 Million USD | 99.055% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 96.295% |
| Silk Road Medical, Inc | -59.27 Million USD | 99.356% |